A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 03 Jan 2017
At a glance
- Drugs Mifepristone (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 28 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2017.
- 24 Jun 2015 Planned End Date changed from 1 Nov 2015 to 1 Nov 2017 as reported by ClinicalTrials.gov.
- 03 Mar 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Jan 2015 to 1 Nov 2015.